Fungi More or Less Obligately Associated with Humans. Requirements for Designating a Mycosis*

Similar documents
Epidemiology and ecology of fungal diseases

Hyphomycetes & Coelomycetes Identification. Taxonomic Systems for Identification of the Anamorphs of Conidiogenous Fungi

Hyphomycetes & Coelomycetes Identification

Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I

Pneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.)

Epidemiology and Laboratory Diagnosis of Fungal Diseases

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

ECMM Excellence Centers Quality Audit

Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance 13

Introduction. Study of fungi called mycology.

Epidemiology of Fungal Diseases

Ali Alabbadi. Sarah Jaar ... Nader

2046: Fungal Infection Pre-Infusion Data

Fungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA

محاضرة مناعت مدرس المادة :ا.م. هدى عبدالهادي علي النصراوي Immunity to Infectious Diseases

Histoplasmosis. Disease Etiology: Disease Transmission: Reservoirs: Specific Microbial Characteristics: By: Ernest Aguilar

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4

Chapter 1. Full file at

Management of fungal infection

The Differentiation of Yeast and Yeast-Like Forms in Human Tissues. Introduction. Histochemical Stains Used to Detect Fungi. Histopathologic Diagnoses

Foundations in Microbiology

Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

and the Working Group from the EMBO-AIDS Related Mycoses Workshop Institute of Infectious Disease and Molecular Medicine, University of Cape Town,

The goal of teaching:

Immunodeficiencies HIV/AIDS

Immunology. Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency

2/18/19. Case 1. Question

MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis

RESERVOIRS OF INFECTION

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Itraconazole DIGICON. Composition: MOLECULAR INTRODUCTION

PARASITOLOGY CASE HISTORY 10 (HISTOLOGY) (Lynne S. Garcia)

number Done by Corrected by Doctor د.حامد الزعبي

Principles of Disease and Epidemiology Chapter 14. Biology 1009 Microbiology Johnson-Summer 2003

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Opportunistic Mycoses

Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH]

Medical Mycology. Dr. Hala Al Daghistani

Mycology. BioV 400. Clinical classification. Clinical classification. Fungi as Infectious Agents. Thermal dimorphism. Handout 6

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

Immune system. Aims. Immune system. Lymphatic organs. Inflammation. Natural immune system. Adaptive immune system

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi Medical Microbiology

Medical Mycology. Dr. Hala Al Daghistani

8/2/10. Sanaz Jalali, Jennifer Demler, Jeremy King. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system.

PATHOGENICITY OF MICROORGANISMS

The Immune System & Non- Infectious Disease. Ch. 18: Sections 1, 2, & 4

Dermatophytes Dr. Hala Al Daghistani

Innate Immunity. Bởi: OpenStaxCollege

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP

Mycology. BioV 400. Subcutaneous Mycoses. Ecological associations. Geographic distribution World-wide

Transplantation. Immunology Unit College of Medicine King Saud University

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

LUNG FUNGUS PRESENTED WITH NODULES- A CASE REPORT

Paracoccidiomycosis and HIV/AIDS: A Common Problem in an Uncommon Location

Case Studies in Fungal Infections and Antifungal Therapy

HISTOPLASMOSIS - LABORATORY DIAGNOSIS IN VIETNAM

Tuberculosis Intensive

Tuberculosis Pathogenesis

BASIC COMPATIBILITY. Pl Path 604

HS161 MIDTERM 3/24/04

Immunity to Malaria Immunity to sporozoites injected by mosquito Mediated by antibody that prevents infection of liver cells

Nonspecific External Barriers skin, mucous membranes

A CASE REPORT OF: PSEUDOMEMBRANOUS CANDIDIASIS INDUCED BY LONG TERM SYSTEMIC CORTICOSTEROIDS THERAPY

PREVENTION OF INFECTIONS IN THE IMMUNOCOMPROMISED. Jo-Anne A. de Castro, MD, FPPS, FPIDSP

Appropriate utilization of the microbiology laboratory. 11 April 2013

EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS

THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE

Mycotic Infections. A. The fungi represent a diverse, heterogeneous group of eukaryotic

Pneumonia in immunosuppressed patients

Hospital-acquired Pneumonia

Aspergillosis in the critically ill patient

Pathogens and the immune system

Candida Alicans & Systemic Candidiasis By Kurt W. Donsbach READ ONLINE

Invasive Pulmonary Aspergillosis in

1. Multiple choice (30 2 each); circle the number of the correct choice. b. Trichophyton schoenleinii is traditionally most associated with

Immunological Aspects of Parasitic Diseases in Immunocompromised Individuals. Taniawati Supali. Department of Parasitology

Diagnostic Procedures for Pulmonary Infiltrates in the Compromised Host

Diagnostik invasiver Pilzinfektionen

OpenStax-CNX module: m Innate Immunity. OpenStax College. Abstract

Histoplasmosis. *resolution protective immunity. a 1 o "endemic" mycosis; 1 o "pulmonary" mycosis

Aspergillus species. The clinical spectrum of pulmonary aspergillosis

8/11/2015. Febrile neutropenia Bone marrow transplant Immunosuppressant medications

Chapter 25. Learning Objectives. Learning Objectives (Cont d) 9/10/2012. Immune System Disorders

Voriconazole October 2015 Risk Management Plan. Voriconazole

Chapter 24 The Immune System

Invasive Aspergillosis in Steroid-Treated Patients

Pulmonary Infections: Fungus. Part I: Background Information and Dimorphic Fungus. Part II: Opportunistic Yeast and Molds

May 14, Review for final exam (May 21, 2011, 8 AM)

Common Fungi. Catherine Diamond MD MPH

Antifungal drugs Dr. Raz Muhammed

Epidemiology. Foundation of epidemiology:

Lecture 10 Immune System

Transcription:

P Fungi More or Less Obligately Associated with Humans a. a few dermatophytes (the anthropophilic species ) b. Malassezia furfur c. Candida albicans d. + Lacazia (Loboa) loboi*p e. + Pneumocystis jirovecii*p *recently confirmed molecularly to be a fungus name recently changed from P. carinii for human agent + Pnot culturable Requirements for Designating a Mycosis* 1. presentation of adequate clinical history that suggests fungal infection; usually provided by patient 2. observation of fungus in clinical specimens; serology or molecular detection can substitute today, sometimes even CT or MRI data for initial ID 3. fungus observed is compatible with disease state reported 4. adequate evidence is presented that causative agent is actually a fungus that was properly identified *1979-174 species of fungi met these requirements Today - many more again (250-400??), and increasing by the month. Reasons for Paucity of Awareness 1. general lack of government reporting requirements* 2. relative difficulty in documenting the existance of fungal disease: for all but relative few, need to culture 3. fungal diseases are generally not communicable + 4. exact mycosis or relevance of mycosis is often difficult to establish 5. some organisms only recently defined as fungi *only 2 are required to be reported to CDC (histoplasmosis & coccidiodomycosis). +exception may be Pneumocystis jirovecii 1

MAIN POINTS OF FIRST LECTURE(S) 1. Mycoses are more or less accidental. 2. Reservoir of infecting units is usually nature (endemic vs epidemic - communicable) 3. More and more species of fungi are being implicated in mycoses. 4. More and more cases of life-threatening mycoses are being diagnosed each year. 5. Mycoses are not all that rare*. 6. Mycoses are probably worthy of more attention and earlier consideration during diagnosis than they often receive * and it is scientifically dihonest to say they are. Why Increased Number of Cases? a. an increased awareness, and better and more specific mycological training among professionals; b. an increase in the number of human hosts that are being compromised or otherwise becoming more susceptible. Note: Fungi are probably not becoming more virulent. However, some are starting to develop antifungal resistence. Some Factors Predisposing Humans to Fungal Infections 1. prolonged antibiotic therapy 2. underlying disease (HIV infection, cancer, diabetes, etc.) 3. age 4. surgical procedures 5. immunosuppressive drugs 6. radiation therapy 7. indwelling catheters 8. obesity 9. drug addiction 10. transplants 11. burns 12. travel, heatstroke, etc. _ Host Deficiencies in Bone Marrow Transplant Recipients Lymphopenia and T and B cell dysfunction for several months Neutropenia for 1 month Breakdown of mucosal barriers Deficient neutrophil chemotaxis and killing of intracellular organisms Dysfunction of pulmonary macrophages Graft-versus-host disease and its therapy perpetuate host deficiencies _ 2

Two Groups of Pathogenic Fungi Based on Virulence 1. "Primary Pathogens": Fungi that are free-living and commonly pathogenic in normal hosts and severely pathogenic in compromised or otherwise predisposed hosts. 2. "Secondary Pathogens": Fungi that are free-living or exo-/endo-symbionts and are generally, but not exclusively, pathogenic only in compromised hosts (so-called secondary or opportunistic pathogens; distinction often blurred). What Fungus Must Do to Infect 1. Gain entry to body interior via a) lungs or other orifices b) traumatic implantation c) invasion of deeper tissue to produce systemic infection 2. Multiply or grow in volume in the host to sufficient numbers/extent to yield symptoms 3. Resist (or at least not stimulate) host defenses 4. Live by utilizing host tissue &/or fluids as a food source a. produces tissue damage (necrosis) b. produces tissue irritation (rash, inflammation, granuloma formation, etc.) _ Factors that Affect Host-Fungus Interactions *virulence factors **host factors a) Those that allow fungus to enter host and cause disease* b) Those of the host that either limit the growth or the survival of the fungus in tissue** 3

Reasons* Why Some Fungi are Pathogenic 1. able to grow at elevated temperatures (35-40 or 41 o C; a few at 45 o C or slightly higher)** 2. able to grow under reduced oxidation/reduction potentials 3. able to avoid efficient, innate and cell-mediated immunity systems of humans, or at least not stimulate them*** * primary virulence factors? ** dermatophytes slightly lower (32-34 o C) *** involves secondary virulence factors (area of intense research) 1. Dimorphism? Polymorphism? (vegetative) 2. Capsules** 3. Cell walls β-glucans chitin** chitosan melanin** mannoprotein surface hydrophobicity surface antigens 4. Siderophores/Fe 3+ reductases 5. Unique membranes 6. Secretory enzymes phospholipases** proteases** 7.??????? Miscellaneous Virulence Factors* *secondary virulence factors? **well established in mouse models for some fungi 4

REVIEW MAIN POINTS OF FIRST LECTURE(S) 1. Mycoses are more or less accidental. 2. Reservoir of infecting units is usually nature (endemic vs epidemic - communicable) 3. More and more species of fungi are being implicated in mycoses. 4. More and more cases of life-threatening mycoses are being diagnosed each year. 5. Mycoses are not all that rare*. 6. Mycoses are probably worthy of more attention and earlier consideration during diagnosis than they often receive * and it is scientifically dihonest to sy they are. _ Early Diagnosis of Invasive Fungal Infections Benefits Early diagnosis permits therapy of maximal effectiveness Early intervention with antifungal therapy may help decrease the high mortality rate associated with serious systemic mycoses Obstacles Because of immunosuppression, typical signs and symptoms of infection are frequently absent Few clinical features are uniquely specific for systemic fungal infection Sputum and blood cultures are frequently negative Invasive procedures o May be necessary for definitive diagnosis o Are often contraindicated in severely immunocompromised patients 5